Navigation Links
Debiopharm Group and Mercury Therapeutics, Inc. Sign an Exclusive License Agreement for the Development and Commercialisation of Debio 0930
Date:8/4/2009

Neal Birnberg, CEO of Mercury, who was advised on this transaction by Katan Associates.

About Diabetes

Diabetes is a disease in which the body does not produce or properly use insulin. Insulin is a hormone that is needed to convert sugar, starches and other food into energy needed for daily life. The cause of diabetes continues to be a mystery, although both genetics and environmental factors such as obesity and lack of exercise appear to play roles.

Prevalence of diabetes worldwide is estimated at 180 million people, WHO predicts this number will rise to 366 million by 2030.

Type 2 diabetes (formerly called non-insulin-dependent or adult-onset) results from the body's ineffective use of insulin. Type 2 diabetes comprises 90% of people with diabetes around the world, and is largely the result of excess body weight and physical inactivity.

About Debiopharm Group

Debiopharm Group is a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs. The group in-licenses promising biological and small molecule drug candidates. It develops its products for global registration and maximum commercial potential. Once registered, the products are out-licensed to pharmaceutical partners for sales and marketing.

Debiopharm independently funds the worldwide development of all of its products while providing expertise in pre-clinical and clinical trials, manufacturing, drug delivery and formulation, and regulatory affairs.

Founded in 1979 and headquartered in Lausanne, Switzerland, Debiopharm has developed four products with global combined sales of $2.6 billion in 2008.

For more information on Debiopharm Group, please visit: http://www.debiopharm.com

About Mercury Therapeutics, Inc.


'/>"/>
SOURCE The Debiopharm Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations
2. Swissmedic Grants Debiopharm Marketing Authorisation for Moapar(R), a New Therapeutic Avenue for the Treatment of Sexual Deviations
3. Salvacyl(R), Developed by Debiopharm, is Launched in two European Countries
4. Clinical Update - Debio 9902 SR (ZT-1) for Alzheimer Patients Debiopharm Starts Tablet Formulations Bridging Study under IND
5. Debiopharm Moves Towards a New 6-Month Formulation of Decapeptyl(R) to Further Help Prostate Cancer Patients
6. Debiopharm and EPFL Sign Research Project Agreement to Identify Inhibitors of Signalling Pathways Controlling Cell Fate for Cancer Treatment
7. Commonwealth Fund Case Study Points to Continuous Innovation at Group Health Cooperative
8. Top Medical Research Centers Form Velos Advisory Group for Service-Oriented Architecture
9. New Federal Stem Cell Rules Would Hinder Existing Research, Consumer Group Warns
10. Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
11. The Villa Group Informs on Mexico Travel Plans in Wake of Swine Flu Outbreak
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2015)... MONMOUTH JUNCTION, N.J. , May 4, 2015 ... critical care immunotherapy company commercializing its CytoSorb® extracorporeal ... patients in multiple countries worldwide, will report Q1 ... Monday, May 11, 2015.  CytoSorbents, ... presentation webcast that will recount both operational and ...
(Date:5/4/2015)... , May 4, 2015 Dynatronics ... manufacturer and marketer of rehabilitation and physical therapy ... definitive agreements to raise approximately $4,000,000 in a ... and certain of its affiliates (together with its ... on the healthcare industry. The financing will provide ...
(Date:5/4/2015)... ROCKVILLE, Md. , May 4, 2015   ... of pathogen-specific therapeutics focused on protecting the microbiome, as ... Shallcross has been appointed Chief Financial Officer, Treasurer ... C. Evan Ballantyne who will be leaving the ... Mr. Shallcross brings to Synthetic Biologics operational, financial and ...
Breaking Medicine Technology:CytoSorbents to Report Q1 2015 Operating and Financial Results 2CytoSorbents to Report Q1 2015 Operating and Financial Results 3Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 2Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 3Dynatronics Announces $4,000,000 Private Placement Led By Prettybrook Partners 4Steven Shallcross Named Chief Financial Officer of Synthetic Biologics 2Steven Shallcross Named Chief Financial Officer of Synthetic Biologics 3
... , Inc., a full-service contract research organization (CRO), and ... combat the growing issue of antibiotic resistance, have partnered ... walk to benefit the Cystic Fibrosis (CF) Foundation through ... Aptalis Pharma) are also working together on clinical trials ...
... May 2, 2012  Neurocrine Biosciences, Inc. (NASDAQ: NBIX ... March 31, 2012.  For the first quarter of 2012, the ... per share, compared with a net income of $2.9 million, ... 2011. This $3.8 million change in operating results is primarily ...
Cached Medicine Technology:Synteract and Rempex Partner in "Great Strides" Walk to Support Cystic Fibrosis Cure 2Neurocrine Biosciences Reports First Quarter 2012 Results 2Neurocrine Biosciences Reports First Quarter 2012 Results 3Neurocrine Biosciences Reports First Quarter 2012 Results 4Neurocrine Biosciences Reports First Quarter 2012 Results 5Neurocrine Biosciences Reports First Quarter 2012 Results 6
(Date:5/4/2015)... UT (PRWEB) May 04, 2015 Pricing ... (up to $3,000) of one patient receiving care at ... Utah. The procedure must be performed by July 15th, ... to pay in full up front and forego the filing ... becomes more economically burdensome every year, and it devastates more ...
(Date:5/4/2015)... 2015 Unlike some camps, the Nike Middle School ... The goal is to educate first and train second, with a ... that the young runners are building the knowledge base needed to ... the topics covered include Effort Based Training, Running Heroes, Running Vocabulary, ... be? This is not a camp where kids come to ...
(Date:5/4/2015)... 2015 World T.E.A.M. Sports’ best-attended ... in the last decade arrived in this historic Civil ... two days from the Pentagon in Arlington, Virginia. The ... disabled and able-bodied participants work together to successfully complete ... honors the commitment and sacrifices by military veterans in ...
(Date:5/4/2015)... 04, 2015 The Accreditation ... the first-ever congenital heart disease (CHD) standards ... (PCCL) accreditation. Driven by the latest available ... comprehensive review of interventional procedures in pediatric ... , “The ACE CHD Standards for PCCL ...
(Date:5/3/2015)... AvePoint, the established ... devices, today announced it is a Platinum Sponsor ... Asia Privacy Forum, taking place May 5-6, 2015 ... AvePoint will showcase its compliance, risk, and privacy ... Visit AvePoint for New Solutions , Attendees ...
Breaking Medicine News(10 mins):Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 2Health News:Pricing Healthcare to Pay a Patient's Bill for a Procedure at Utah Facility 3Health News:US Sports Camps and Select Nike Running Camps Offer Programs for Middle School Runners 2Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 2Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 3Health News:Gettysburg Welcomes Arriving Face of America Riders with Gala Celebration 4Health News:Accreditation for Cardiovascular Excellence (ACE) Publishes New Standards for Pediatric and Adult Congenital Cardiac Catheterization Laboratories 2Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 2Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 3Health News:AvePoint Showcases Compliance and Data Privacy Solutions as Platinum Sponsor of IAPP Asia Privacy Forum 2015 4
... Lemon Grove Care & Rehabilitation Center has responded ... a "AA" citation issued to the 158-bed skilled ... )"We stand by the quality of care we ... the Department,s assessment of the facts surrounding this ...
... women at certain times of year, study finds , , FRIDAY, ... people,s attempts to get regular exercise, suggests a U.S. study ... and less in the winter. , The study involved ... 18 months. Based on pedometer readings, the women,s step counts ...
... College of Optometry students receive a Jenzabar Foundation grant to impact ... ... (PRWEB) February 13, 2009 -- Even in this uncertain economy, ... and wallets to volunteer for domestic and global humanitarian missions through ...
... Treat Diseases, Inc. (HTDS) ( www.htdsmedical.com ) has entered ... company that has developed a radically new product which ... the FDA approval (or authority equivalent to the specific ... FDA approved. , HTDS Andrea Zecevic-Rubio, Chief Project Scientist, ...
... 13 American Network, Inc., announced today that it ... for the Deaf and Hard of Hearing communities. ... a great success as it forays into TRS with ... and Hard of Hearing.PhoneCaption,s service uses innovative, patent-pending technology ...
... Feb. 13 Six Miami-Dade County residents have been ... fraud scheme operated out of Midway Medical, a Miami ... Acting Assistant Attorney General Rita M. Glavin of the ... the Southern District of Florida announced.Carmen Lourdes del Cueto, ...
Cached Medicine News:Health News:Lemon Grove Care & Rehabilitation Center Responds to Health Department Announcement 2Health News:Winter's Cold, Summer's Heat Take a Toll 2Health News:Cash-strapped Optometry Students Give Back in a Big Way 2Health News:Cash-strapped Optometry Students Give Back in a Big Way 3Health News:Cash-strapped Optometry Students Give Back in a Big Way 4Health News:Hard To Treat Diseases (HTDS) Negotiating to Merge with a UK Health Care Company 2Health News:PhoneCaption Provides Free Captioning Services for Deaf and Hard of Hearing 2Health News:Three Miami Physicians and Three Medical Workers Charged With $10 Million Medicare Fraud Scheme 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: